跳至主要内容
临床试验/JPRN-UMIN000001444
JPRN-UMIN000001444已完成4 期

Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS cancer. - Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS cancer. (KSCC0803 study)

KSCC0 个研究点目标入组 92 人开始时间: 2008年10月22日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Pregnant or nursing 2)Medical history of allergy or hypersensitivity reactions to fluoropyrimidines 3)The past of the internal organ transplant 4)Serious coexisting illness a;severe pulmonary dysfunction b;ileus or colon dysfunction c;uncontrolled diabetes mellitus d;liver cirrhosis e;uncontrolled hypertension f;history of myocardial infarction, unstable angina within 6 months prior to the registration 5)Active synchronous or metachronous malignancy other than carcinoma in situ 6)Uncontrollable infectious disease 7)Not suitable for participating in the study for any other reason

研究者

发起方
KSCC

相似试验

Feasibility study of Capecitabine as adjuvant... | 临床试验